Clinical Trial Update: C-Cure Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

The C-Cure clinical trial sponsored by Celyad Oncology SA has completed Phase 2 and Phase 3 testing for heart failure (NYHA Class II-III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• C-Cure

Snippet

Sponsor: Celyad Oncology SA | Conditions: Heart Failure Class II or III | Phase 2, Phase 3 | Status: COMPLETED